PL2215214T3 - Pożywki dla pluripotencjalnych komórek macierzystych wolne od komórek odżywczych zawierające ludzką surowicę - Google Patents

Pożywki dla pluripotencjalnych komórek macierzystych wolne od komórek odżywczych zawierające ludzką surowicę

Info

Publication number: PL2215214T3
Authority: PL; Poland
Prior art keywords: feeder; stem cell; human serum; pluripotent stem; media containing
Prior art date: 2007-10-19

Application number

PL08840374T

Other languages

English (en)

Inventor

Allan J. Robins

Thomas C. Schulz

Eugene P. Brandon

Original Assignee

Viacyte, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-19

Filing date

2008-10-20

Publication date

2018-08-31

2008-10-20 Application filed by Viacyte, Inc. filed Critical Viacyte, Inc.

2018-08-31 Publication of PL2215214T3 publication Critical patent/PL2215214T3/pl

Links

210000001778 pluripotent stem cell Anatomy 0.000 title 1
210000002966 serum Anatomy 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
- C12N5/068—Stem cells; Progenitors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/98—Xeno-free medium and culture conditions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Developmental Biology & Embryology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PL08840374T 2007-10-19 2008-10-20 Pożywki dla pluripotencjalnych komórek macierzystych wolne od komórek odżywczych zawierające ludzką surowicę PL2215214T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/875,057 US8623650B2 (en)	2007-10-19	2007-10-19	Methods and compositions for feeder-free pluripotent stem cell media containing human serum
PCT/US2008/080516 WO2009052505A1 (en)	2007-10-19	2008-10-20	Feeder-free pluripotent stem cell media containing human serum
EP08840374.6A EP2215214B1 (en)	2007-10-19	2008-10-20	Feeder-free pluripotent stem cell media containing human serum

Publications (1)

Publication Number	Publication Date
PL2215214T3 true PL2215214T3 (pl)	2018-08-31

Family

ID=40563869

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08840374T PL2215214T3 (pl)	2007-10-19	2008-10-20	Pożywki dla pluripotencjalnych komórek macierzystych wolne od komórek odżywczych zawierające ludzką surowicę

Country Status (10)

Country	Link
US (7)	US8623650B2 (pl)
EP (3)	EP2215214B1 (pl)
CN (2)	CN104498432B (pl)
AU (1)	AU2008311798B2 (pl)
CA (1)	CA2703116C (pl)
DK (1)	DK3375867T3 (pl)
ES (2)	ES2674239T3 (pl)
IL (5)	IL297378B2 (pl)
PL (1)	PL2215214T3 (pl)
WO (1)	WO2009052505A1 (pl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003014313A2 (en) *	2001-08-06	2003-02-20	Bresagen, Ltd.	Alternative compositions and methods for the culture of stem cells
US8187878B2 (en)	2004-08-13	2012-05-29	University Of Georgia Research Foundation, Inc.	Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors
SG170021A1 (en)	2006-02-23	2011-04-29	Novocell Inc	Compositions and methods useful for culturing differentiable cells
US8623650B2 (en)	2007-10-19	2014-01-07	Viacyte, Inc.	Methods and compositions for feeder-free pluripotent stem cell media containing human serum
US8338170B2 (en) *	2008-04-21	2012-12-25	Viacyte, Inc.	Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
US20090298178A1 (en) *	2008-06-03	2009-12-03	D Amour Kevin Allen	Growth factors for production of definitive endoderm
US8895300B2 (en)	2008-11-04	2014-11-25	Viacyte, Inc.	Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
US8008075B2 (en) *	2008-11-04	2011-08-30	Viacyte, Inc.	Stem cell aggregate suspension compositions and methods of differentiation thereof
JP2012508584A (ja) *	2008-11-14	2012-04-12	ヴィアサイト，インコーポレイテッド	ヒト多能性幹細胞由来膵臓細胞のカプセル化
US9109245B2 (en)	2009-04-22	2015-08-18	Viacyte, Inc.	Cell compositions derived from dedifferentiated reprogrammed cells
US9018010B2 (en)	2009-11-12	2015-04-28	Technion Research & Development Foundation Limited	Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
US9433557B2 (en)	2011-02-21	2016-09-06	Viacyte, Inc.	Loading system for an encapsulation device
JOP20200043A1 (ar)	2011-05-10	2017-06-16	Amgen Inc	طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
EA039663B1 (ru)	2012-05-03	2022-02-24	Амген Инк.	Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств
AU2013248265B2 (en) *	2012-11-08	2018-11-01	Viacyte, Inc.	Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
AU2014225352B2 (en)	2013-03-07	2017-02-09	Viacyte, Inc.	3-dimensional large capacity cell encapsulation device assembly
USD720469S1 (en)	2013-03-07	2014-12-30	Viacyte, Inc.	Cell encapsulation device
US8859286B2 (en)	2013-03-14	2014-10-14	Viacyte, Inc.	In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
CN120796168A (zh)	2013-06-11	2025-10-17	哈佛学院校长同事会	SC-β细胞以及用于产生其的组合物和方法
US11051900B2 (en)	2014-04-16	2021-07-06	Viacyte, Inc.	Tools and instruments for use with implantable encapsulation devices
WO2016100898A1 (en)	2014-12-18	2016-06-23	President And Fellows Of Harvard College	Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof
CN107614678B (zh)	2014-12-18	2021-04-30	哈佛学院校长同事会	干细胞来源的β细胞的产生方法及其使用方法
EP3234110B1 (en)	2014-12-18	2024-02-28	President and Fellows of Harvard College	METHODS FOR GENERATING STEM CELL-DERIVED ß CELLS AND USES THEREOF
CA3042495A1 (en)	2016-11-10	2018-05-17	Viacyte, Inc.	Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
CN111565707A (zh)	2017-06-14	2020-08-21	森玛治疗公司	用于递送治疗物的装置和方法
US10391156B2 (en)	2017-07-12	2019-08-27	Viacyte, Inc.	University donor cells and related methods
EP3710021A4 (en)	2017-11-15	2021-08-11	Semma Therapeutics, Inc.	ISLAND CELL MANUFACTURING COMPOSITIONS AND METHOD OF USE
WO2020033879A1 (en)	2018-08-10	2020-02-13	Semma Therapeutics, Inc.	Stem cell derived islet differentiation
US12378572B2 (en)	2018-09-07	2025-08-05	Crispr Therapeutics Ag	Universal donor cells
CN110373375A (zh) *	2019-03-19	2019-10-25	杭州原生生物科技有限公司	一种制备纤维细胞作为细胞培养基的方法和用途
EP3976236A1 (en)	2019-05-31	2022-04-06	W.L. Gore & Associates Inc.	A biocompatible membrane composite
EP3975926A1 (en)	2019-05-31	2022-04-06	W.L. Gore & Associates, Inc.	A biocompatible membrane composite
CA3139292C (en)	2019-05-31	2025-06-10	Viacyte, Inc.	CELL ENCAPSULATION DEVICES WITH REGULATED OXYGEN DIFFUSION DISTANCES
CN114173837A (zh)	2019-05-31	2022-03-11	W.L.戈尔及同仁股份有限公司	生物相容性膜复合材料
JP2022546578A (ja) *	2019-09-04	2022-11-04	ブイセルセラピューティックス，インコーポレイテッド	癌を処置するためのワクチンおよびストレスリプログラミングによるその作製方法
CA3150235A1 (en)	2019-09-05	2021-03-11	Alireza Rezania	Universal donor cells
PH12022550542A1 (en)	2019-09-05	2023-03-20	Crispr Therapeutics Ag	Universal donor cells
WO2022144855A1 (en)	2020-12-31	2022-07-07	Crispr Therapeutics Ag	Universal donor cells

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4309418A (en)	1980-03-25	1982-01-05	Sloan-Kettering Research Institute For Cancer	Anti-tumor agent from human serum and process
US5453357A (en) *	1992-10-08	1995-09-26	Vanderbilt University	Pluripotential embryonic stem cells and methods of making same
US5843780A (en) *	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
JP2001517927A (ja)	1996-02-28	2001-10-09	バンダービルトユニバーシティ	胚幹細胞を作製する組成物および方法
US6331406B1 (en)	1997-03-31	2001-12-18	The John Hopkins University School Of Medicine	Human enbryonic germ cell and methods of use
CA2307807C (en)	1997-10-23	2008-09-02	Andrea G. Bodnar	Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
CA2324591A1 (en)	1998-04-09	1999-10-21	Bresagen Limited	Cell differentiation/proliferation and maintenance factor and uses thereof
US6875607B1 (en)	1998-11-09	2005-04-05	Es Cell International Pte Ltd	Embryonic stem cells
JP2005503822A (ja) *	2001-09-28	2005-02-10	イーエス・セル・インターナショナル・プライヴェート・リミテッド	無フィーダーマトリックス上での未分化ヒト胚性幹（ｈｅｓ）細胞の導出および増殖方法ならびにヒトフィーダー層
AU2003303071B2 (en) *	2002-12-16	2009-04-23	Technion Research & Development Foundation Ltd.	Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
US7625753B2 (en)	2003-12-23	2009-12-01	Cythera, Inc.	Expansion of definitive endoderm cells
US8647873B2 (en)	2004-04-27	2014-02-11	Viacyte, Inc.	PDX1 expressing endoderm
WO2005065354A2 (en) *	2003-12-31	2005-07-21	The Burnham Institute	Defined media for pluripotent stem cell culture
CN101048495A (zh) *	2004-04-27	2007-10-03	赛瑟拉公司	表达pdx1的内胚层
CN101023163A (zh) *	2004-07-09	2007-08-22	赛瑟拉公司	鉴定用于分化定型内胚层的因子的方法
US8597947B2 (en) *	2004-12-29	2013-12-03	Hadasit Medical Research Services & Development Limited	Undifferentiated stem cell culture systems
WO2007002664A2 (en) *	2005-06-22	2007-01-04	Massachusetts Institute Of Technology	Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel
SG170021A1 (en) *	2006-02-23	2011-04-29	Novocell Inc	Compositions and methods useful for culturing differentiable cells
US7964402B2 (en) *	2006-05-25	2011-06-21	Sanford-Burnham Medical Research Institute	Methods for culture and production of single cell populations of human embryonic stem cells
KR101685246B1 (ko) *	2006-07-14	2016-12-09	디피엑스 홀딩스 비.브이.	개선된 세포 배양 방법
US8623650B2 (en)	2007-10-19	2014-01-07	Viacyte, Inc.	Methods and compositions for feeder-free pluripotent stem cell media containing human serum

2007
- 2007-10-19 US US11/875,057 patent/US8623650B2/en active Active
2008
- 2008-10-20 WO PCT/US2008/080516 patent/WO2009052505A1/en not_active Ceased
- 2008-10-20 EP EP08840374.6A patent/EP2215214B1/en active Active
- 2008-10-20 IL IL297378A patent/IL297378B2/en unknown
- 2008-10-20 ES ES08840374.6T patent/ES2674239T3/es active Active
- 2008-10-20 ES ES18171601T patent/ES2971288T3/es active Active
- 2008-10-20 PL PL08840374T patent/PL2215214T3/pl unknown
- 2008-10-20 CN CN201410640785.9A patent/CN104498432B/zh active Active
- 2008-10-20 AU AU2008311798A patent/AU2008311798B2/en active Active
- 2008-10-20 EP EP18171601.0A patent/EP3375867B1/en active Active
- 2008-10-20 DK DK18171601.0T patent/DK3375867T3/da active
- 2008-10-20 EP EP24152287.9A patent/EP4368701A3/en active Pending
- 2008-10-20 CA CA2703116A patent/CA2703116C/en active Active
- 2008-10-20 IL IL283597A patent/IL283597B2/en unknown
- 2008-10-20 CN CN200880121734.8A patent/CN101903515B/zh active Active
2010
- 2010-04-15 IL IL205115A patent/IL205115A/en active IP Right Grant
- 2010-08-15 US US12/856,662 patent/US8334138B2/en active Active
2013
- 2013-12-10 US US14/102,451 patent/US9267110B2/en active Active
2015
- 2015-04-21 IL IL238395A patent/IL238395B/en active IP Right Grant
2016
- 2016-02-22 US US15/050,069 patent/US10246680B2/en active Active
2019
- 2019-04-01 US US16/372,358 patent/US10808223B2/en active Active
- 2019-06-16 IL IL267371A patent/IL267371B/en active IP Right Grant
2020
- 2020-10-19 US US17/074,481 patent/US11920154B2/en active Active
2023
- 2023-09-26 US US18/373,014 patent/US20240218324A1/en active Pending

Also Published As

Publication number	Publication date
ES2674239T8 (es)	2019-01-16
US20160222346A1 (en)	2016-08-04
US10808223B2 (en)	2020-10-20
IL297378A (en)	2022-12-01
CN104498432A (zh)	2015-04-08
IL283597A (en)	2021-07-29
US10246680B2 (en)	2019-04-02
IL205115A0 (en)	2010-12-30
EP4368701A3 (en)	2024-09-04
IL205115A (en)	2015-10-29
US20190225938A1 (en)	2019-07-25
EP3375867B1 (en)	2024-01-24
EP2215214A1 (en)	2010-08-11
EP2215214B1 (en)	2018-05-16
US20100311164A1 (en)	2010-12-09
CN101903515B (zh)	2014-12-10
EP4368701A2 (en)	2024-05-15
CN101903515A (zh)	2010-12-01
WO2009052505A1 (en)	2009-04-23
IL297378B1 (en)	2024-11-01
US8334138B2 (en)	2012-12-18
AU2008311798B2 (en)	2014-05-01
EP2215214A4 (en)	2012-09-05
US20090104696A1 (en)	2009-04-23
US9267110B2 (en)	2016-02-23
IL283597B2 (en)	2023-03-01
IL283597B (en)	2022-11-01
EP3375867A1 (en)	2018-09-19
ES2971288T3 (es)	2024-06-04
DK3375867T3 (da)	2024-04-02
IL238395B (en)	2019-06-30
CA2703116A1 (en)	2009-04-23
AU2008311798A1 (en)	2009-04-23
IL297378B2 (en)	2025-03-01
US20240218324A1 (en)	2024-07-04
ES2674239T3 (es)	2018-06-28
US11920154B2 (en)	2024-03-05
CA2703116C (en)	2019-01-08
IL267371B (en)	2021-06-30
US20210047616A1 (en)	2021-02-18
IL267371A (en)	2019-08-29
US20140099713A1 (en)	2014-04-10
IL238395A0 (en)	2015-06-30
CN104498432B (zh)	2023-08-11
US8623650B2 (en)	2014-01-07

Publication	Publication Date	Title
IL283597A (en)	2021-07-29	A pluripotent stem cell growth medium containing human serum and without a nutrient layer
PL2046946T3 (pl)	2017-04-28	Hodowla pluripotencjalnych komórek macierzystych
ZA201000715B (en)	2011-04-28	Single pluripotent stem cell culture
ZA201606403B (en)	2018-05-30	Pluripotent stem cell culture on micro-carriers
EP2142641A4 (en)	2010-08-18	UNDIFFERENCED STEM CELL CULTURAL SYSTEMS
GB2458863B (en)	2011-10-12	Improved culture of stem cells
PL2254586T3 (pl)	2015-09-30	Cząstki mezenchymalnych komórek macierzystych
PL2393917T3 (pl)	2016-12-30	Podłoże do hodowli nabłonkowych komórek macierzystych i organoidów zawierających komórki macierzyste
PL3121266T3 (pl)	2020-07-13	Wolne od oligopeptydów pożywki do hodowli komórkowej
EP2155859A4 (en)	2010-06-30	FORMULATIONS AND METHODS FOR CULTIVATING EMBRYONIC STEM CELLS
IL228818A0 (en)	2013-12-31	Stem cell cultures
EP2398896A4 (en)	2013-02-20	CELL CULTURE MEDIUM CONTAINING COMBINATIONS OF PROTEINS
SG10201500674YA (en)	2015-04-29	Pluripotent stem cells
PL2283113T3 (pl)	2017-09-29	Pluripotencjalne komórki
GB2460552B (en)	2011-09-07	Stem cell culture media and methods
EP1991666A4 (en)	2009-06-10	NON-EMBRYONIC TOTIPOTENT STEM CELLS OF BLASTOMERIC TYPE AND METHODS
GB0623635D0 (en)	2007-01-03	Pluripotent cell growth media
GB0525579D0 (en)	2006-01-25	Cell culture vessel
EP2294182A4 (en)	2013-01-02	CULTS OF MULTIPOTENT STEM CELLS
AU2014201623B2 (en)	2016-03-31	Pluripotent stem cell culture
IL201166A0 (en)	2010-05-17	Undifferentiated stem cell culture systems
GB0810304D0 (en)	2008-07-09	Stem cell culture media and methods
GB0821363D0 (en)	2008-12-31	Stem cell culture media and methods
HK1154890A (en)	2012-05-04	Multipotent stem cell cultures
GB0724994D0 (en)	2008-01-30	Mesenchymal stem cell markers